Comparison of a new non-contact automatic ophthalmic optical biometer with an SS-OCT based optical biometer ARGOS.
[PURPOSE] To evaluate the agreement of ocular biometric parameters measured by a novel all-in-one optical low coherence reflectometry (OLCR) biometer (SW-9000 Plus) compared with a swept-source optica
APA
Lin X, Li J, et al. (2026). Comparison of a new non-contact automatic ophthalmic optical biometer with an SS-OCT based optical biometer ARGOS.. Photodiagnosis and photodynamic therapy, 58, 105393. https://doi.org/10.1016/j.pdpdt.2026.105393
MLA
Lin X, et al.. "Comparison of a new non-contact automatic ophthalmic optical biometer with an SS-OCT based optical biometer ARGOS.." Photodiagnosis and photodynamic therapy, vol. 58, 2026, pp. 105393.
PMID
41687758
Abstract
[PURPOSE] To evaluate the agreement of ocular biometric parameters measured by a novel all-in-one optical low coherence reflectometry (OLCR) biometer (SW-9000 Plus) compared with a swept-source optical coherence tomography (SS-OCT) biometer (ARGOS).
[METHODS] 48 eyes of 48 healthy subjects were included. The following parameters were obtained: axial length (AL), central corneal thickness (CCT), anterior chamber depth (ACD), lens thickness (LT), mean keratometry (Km), astigmatism (AST), J, J, corneal diameter (CD) and pupil diameter (PD). Bland-Altman plots and 95% limits of agreement (LoA) were utilized to confirm the concordance between the devices. Participants were categorized into two groups based on AL to facilitate a subgroup analysis (AL > 25 mm or AL < 25 mm).
[RESULTS] The new biometer showed small differences with SS-OCT: AL (0.01 ± 0.03 mm), CCT (4.65 ± 4.29 μm), ACD (-0.11 ± 0.05 mm), LT (0.03 ± 0.08 mm), Km (-0.08 ± 0.18 D), AST (-0.03 ± 0.17 D), J (0 ± 0.09 D), J (-0.05 ± 0.09 D), CD (-1.21 ± 0.36 mm), and PD (-0.37 ± 0.64 mm). For AL > 25 mm and AL < 25 mm, differences were 0.02 ± 0.03 mm and -0.01 ± 0.03 mm. Bland-Altman plots showed narrow 95% LoAs for all except PD (-1.62 to 0.87 mm) and CD (-1.91 to -0.51 mm).
[CONCLUSIONS] The novel all-in-one OLCR biometer showed high agreement with the SS-OCT device for most ocular biometry parameters in healthy eyes. CD and PD demonstrated lower agreement and should not be considered interchangeable between devices.
[METHODS] 48 eyes of 48 healthy subjects were included. The following parameters were obtained: axial length (AL), central corneal thickness (CCT), anterior chamber depth (ACD), lens thickness (LT), mean keratometry (Km), astigmatism (AST), J, J, corneal diameter (CD) and pupil diameter (PD). Bland-Altman plots and 95% limits of agreement (LoA) were utilized to confirm the concordance between the devices. Participants were categorized into two groups based on AL to facilitate a subgroup analysis (AL > 25 mm or AL < 25 mm).
[RESULTS] The new biometer showed small differences with SS-OCT: AL (0.01 ± 0.03 mm), CCT (4.65 ± 4.29 μm), ACD (-0.11 ± 0.05 mm), LT (0.03 ± 0.08 mm), Km (-0.08 ± 0.18 D), AST (-0.03 ± 0.17 D), J (0 ± 0.09 D), J (-0.05 ± 0.09 D), CD (-1.21 ± 0.36 mm), and PD (-0.37 ± 0.64 mm). For AL > 25 mm and AL < 25 mm, differences were 0.02 ± 0.03 mm and -0.01 ± 0.03 mm. Bland-Altman plots showed narrow 95% LoAs for all except PD (-1.62 to 0.87 mm) and CD (-1.91 to -0.51 mm).
[CONCLUSIONS] The novel all-in-one OLCR biometer showed high agreement with the SS-OCT device for most ocular biometry parameters in healthy eyes. CD and PD demonstrated lower agreement and should not be considered interchangeable between devices.
MeSH Terms
Humans; Tomography, Optical Coherence; Biometry; Male; Female; Adult; Reproducibility of Results; Middle Aged; Cornea; Young Adult
같은 제1저자의 인용 많은 논문 (5)
- Cross-disciplinary communication between oral and gut microbiota in head and neck cancer.
- Targeting miR-4653-3p/SLC25A51/SIRT3 axis to induce synthetic lethality in ARID1A-deficient colorectal cancer via blockade of DNA repair.
- A critical role for STAT3 Thr714 phosphorylation in NPM-ALK-driven tumorigenesis.
- Age-Adjusted Charlson Comorbidity Index Guides Risk Stratification for Hepatocellular Carcinoma Patients Treated with TACE Combined with Immune Checkpoint Inhibitors and Targeted Therapy: A Multicenter Retrospective Cohort Study.
- Molecular features of early- vs. late-onset gastric cancer: a systematic review and meta-analysis.